or certolizumab pegol is a drug for treatment of autoimmune diseases. It belongs to tumor necrosis factor (TNF) inhibitors family of drugs. Recently, Cimzia, along with several other TNF blockers, were associated with an increased risk of cancer.

Cimzia is the brand name for certolizumab. It reduces inflammation in the body. It is used for treatment of the symptoms of Crohn’s disease. It is also used for treatment of moderate-to-severe rheumatoid arthritis in adults. It is also used for other purposes. It was approved by in April 2008.

Previous ArticleThe FDAs Many Updates Regarding Actos Next ArticleFDA Announces Black Box Label Warning for Cimzia
Verdicts and Settlements
Contact Us

Subscribe Now!

[contact-form-7 404 "Not Found"]

Follow Us!

Unsafe Drugs has numerous resources on drug side effects,nutritional supplements, vitamins, and health products.

Site best viewed in Google Chrome, Firefox, Opera, Safari, IE browsers